Jeannette Hübener‐Schmid

Nuclear Localization of Ataxin-3 Is Required for the Manifestation of Symptoms in SCA3:<i>In Vivo</i>Evidence

Ulrike Bichelmeier, Thorsten Schmidt, Jeannette Hübener‐Schmid et al. · Journal of Neuroscience · 2007 · 199 citations · Full text

Life Sciences, Genetics, Neurology +17

Neurofilaments in spinocerebellar ataxia type 3: blood biomarkers at the preataxic and ataxic stage in humans and mice

Carlo Wilke, Eva Haas, Kathrin Reetz et al. · EMBO Molecular Medicine · 2020 · 102 citations · Full text

Life Sciences, Neurology, Neuroscience +17

Familial thrombocytosis caused by the novel germ‐line mutation p.Pro106Leu in the <i>MPL</i> gene

El-Harith A. el-HA. El-Harith, Cornelia Roesl, Matthias Ballmaier et al. · British Journal of Haematology · 2008 · 77 citations

Life Sciences, Genetics, Hematology +15

Development of an AAV-Based MicroRNA Gene Therapy to Treat Machado-Joseph Disease

Raygene Martier, Marina Sogorb-González, Janice Stricker-Shaver et al. · Molecular Therapy — Methods & Clinical Development · 2019 · 58 citations · Full text

Life Sciences, Genetics, Neuroscience +17

N-terminal ataxin-3 causes neurological symptoms with inclusions, endoplasmic reticulum stress and ribosomal dislocation

Jeannette Hübener‐Schmid, Franz Vauti, Claudia Funke et al. · Brain · 2011 · 53 citations

Life Sciences, Genetics, Neuroscience +17